When large incumbents leave significant but challenging markets, leaner startups can leverage new technologies to drive change. As big pharmaceutical companies shy away from neurological disease research, Verge Genomics founder and CEO Alice Zhang describes how a confluence of technological advances in genomics is creating new opportunities. New nontraditional biotech companies, she observes, are being built by multidisciplinary teams fluent in both biology and computer science.
Related
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
Jenny Xia Spradling,
FreeWill
Patrick Schmitt,
FreeWill
Building From Values [Entire Talk]
Building a startup on shared values gives entrepreneurs a foundation for company culture and growth.
Jenny Xia Spradling,
FreeWill
Patrick Schmitt,
FreeWill
Building From Values [Entire Talk]
Building a startup on shared values gives entrepreneurs a foundation for company culture and growth.
